CRCbioscreen

next generation colorectal cancer screening

CRCbioscreen has raised EUR 875K seed funding for developing a multitarget faecal immunochemical test for improved colorectal cancer screening.

In collaboration with the Netherlands Cancer Institute, CRC has secured addtional funding from Health˜Holland for executing a prospective screening trial to evaluate the mtFIT head to head to the standard of care FIT in >13,000 participants of the Dutch national colorectal cancer screening program.

Our investors